V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180000690 | 180001912 | null | null | null | 2018-10-10 | 2019-04-15 | Pemetrexed | null | null | ANTIBODY NBL | 100940003 |
| 180000707 | 180001914 | null | null | null | null | 2019-06-04 | Cytarabine High Dose | null | null | NOT MATCHED | 101844229 |
| 180000747 | 180001916 | null | null | null | null | 2014-07-01 | Irinotecan + Modified De Gramont | null | null | CAPECITABINE + OXALIPLATIN | 100445297 |
| 180000768 | 180001917 | null | null | null | null | 2018-06-30 | PACLITAXEL | null | null | NB HRNBL-1 ISOTRETINOIN | 100508215 |
| 180000773 | 180001919 | null | null | null | 2019-11-17 | 2020-07-06 | Capecitabine | null | null | VANDETANIB | 100688001 |
| 180000814 | 180001922 | null | null | null | 2016-02-01 | 2016-03-17 | ESHAP | null | null | SELPERCATINIB | 100615794 |
| 180000960 | 180001928 | null | null | null | null | 2016-08-17 | NB BEACON Temozolomide Irinotecan | null | null | CABAZITAXEL | 101430140 |
| 180001054 | 180001932 | null | null | null | null | 2016-11-20 | CISPLATIN + DOX + ETOPOSIDE + MITOTANE | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101317890 |
| 180001096 | 180001937 | null | null | null | null | 2019-04-17 | null | null | null | NB HRNBL-1 ISOTRETINOIN | 101344798 |
| 180001100 | 180001938 | 1.6 | null | null | null | 2018-01-09 | PACLITAXEL | null | null | DOXORUBICIN | 101382347 |
| 180001158 | 180001942 | null | null | null | null | 2018-12-04 | Dacarbazine | null | null | NB HRNBL-1 ISOTRETINOIN | 101524384 |
| 180001211 | 180001945 | null | null | null | 2021-09-11 | 2021-09-11 | NB HRNBL-1 BUMEL MAT | null | null | LENVATINIB | 101334382 |
| 180001219 | 180001946 | null | null | null | null | 2017-01-11 | DOXORUBICIN | null | null | NB HRNBL-1 ISOTRETINOIN | 100973705 |
| 180001261 | 180001950 | null | null | null | null | 2017-06-22 | Letrozole + Palbociclib | null | null | CARBOPLATIN + VINORELBINE | 101626773 |
| 180001352 | 180001954 | null | null | null | 2020-04-16 | 2020-04-27 | TEMOZOLOMIDE | null | null | LENVATINIB | 101781777 |
| 180001454 | 180001959 | null | null | null | null | 2020-04-25 | CABOZANTINIB | null | null | CETUXIMAB + OXALIPLATIN + MDG | 100652536 |
| 180001530 | 180001964 | null | null | null | 2015-01-20 | 2016-03-17 | null | null | null | CABOZANTINIB | 100392368 |
| 180001538 | 180001965 | null | null | null | null | 2020-11-05 | NB Rel CCLG guidelines Irin & Temoz | null | null | LENVATINIB | 100626527 |
| 180001546 | 180001966 | null | null | null | null | 2018-08-31 | MITOTANE | null | null | LENVATINIB | 101088196 |
| 180001550 | 180001967 | null | null | null | null | 2017-12-14 | Lomustine | null | null | FLUOROURACIL + OXALIPLATIN | 101130115 |
| 180001661 | 180001979 | null | null | null | null | 2020-09-09 | R GCVP | null | null | TRIAL UNSPECIFIED | 101351640 |
| 180001710 | 180001983 | null | null | null | null | 2021-08-07 | null | null | null | TRIAL UNSPECIFIED | 100217952 |
| 180001796 | 180001986 | null | null | null | null | 2022-01-14 | NCRN402 BEACON TRIAL | null | null | ALL UKALL2011 IND A | 100918136 |
| 180001855 | 180001990 | null | null | null | 2019-05-13 | 2020-01-08 | NB HRNBL-1 ch14.18/CHO only (trial) | null | null | CARBOPLATIN + PEMETREXED | 100849373 |
| 180001928 | 180001996 | null | null | null | 2017-02-24 | 2017-03-06 | LENVATINIB | null | null | NB HRNBL-1 COJEC IND COURSE B | 100577579 |
| 180001997 | 180001998 | null | null | null | 2017-06-30 | 2017-06-30 | Cyclophosphamide + Topotecan | null | null | SORAFENIB | 100154149 |
| 180002031 | 180002000 | null | null | null | null | 2019-04-26 | WT Relapsed UKWR, Group C Melphalan | null | null | DINUTUXIMAB BETA | 101142828 |
| 180002084 | 180002001 | null | null | null | null | 2019-03-15 | NB HRNBL-1 ch14.18/CHO only (trial) | null | null | GEMCITABINE | 101584594 |
| 180002095 | 180002002 | null | null | null | 2019-07-05 | 2020-02-25 | Cisplatin | null | null | DOXORUBICIN + IFOSFAMIDE | 100516760 |
| 180002212 | 180002012 | 1.6 | null | null | null | 2020-11-14 | Trial Unspecified | null | null | MITOTANE | 100351119 |
| 180002371 | 180002020 | null | null | null | null | 2020-03-08 | null | null | null | LENVATINIB | 101226723 |
| 180002421 | 180002021 | null | null | null | null | 2019-02-07 | LENVATINIB | null | null | LENVATINIB | 100362278 |
| 180002465 | 180002023 | null | null | null | null | 2016-11-18 | LENVATINIB | null | null | FLUOROURACIL + IRINOTECAN | 100551881 |
| 180002509 | 180002027 | 0.95 | null | null | null | 2016-05-30 | NB HRNBL-1 BUMEL MAT | null | null | LENVATINIB | 100113754 |
| 180002532 | 180002030 | null | null | null | 2018-09-14 | 2018-10-27 | CISPLATIN + DOX + ETOPOSIDE + MITOTANE | null | null | LENVATINIB | 101365730 |
| 180002540 | 180002031 | null | null | null | 2018-11-04 | 2018-12-22 | null | null | null | GEMCARBO | 100088017 |
| 180002554 | 180002032 | null | null | null | null | 2019-04-13 | NB HRNBL-1 COJEC Ind COURSE B | null | null | CAPECITABINE | 100912127 |
| 180002636 | 180002036 | null | null | null | null | 2022-03-31 | Dinutuximab Beta | null | null | CABOZANTINIB | 101247456 |
| 180002768 | 180002046 | null | null | null | null | 2016-06-17 | CISPLATIN + DOXORUBICIN + ETOPOSIDE | null | null | LENVATINIB | 100142127 |
| 180002835 | 180002049 | null | null | null | null | 2017-11-09 | Capecitabine | null | null | CISPLATIN + PEMETREXED | 100474100 |
| 180002878 | 180002052 | null | null | null | 2017-07-17 | 2017-07-18 | Cyclophosphamide High Dose | null | null | NB HRNBL-1 ISOTRETINOIN | 100558438 |
| 180003049 | 180002060 | null | null | null | null | 2019-06-15 | CARBOPLATIN + GEMCITABINE | null | null | NB HRNBL-1 ISOTRETINOIN | 100308659 |
| 180003123 | 180002063 | null | null | null | 2018-07-19 | 2018-09-27 | Venetoclax | null | null | ETOPOSIDE | 101109658 |
| 180003132 | 180002064 | null | null | null | 2019-04-11 | 2019-04-22 | ETOPOSIDE | null | null | LENVATINIB | 100780739 |
| 180003139 | 180002065 | null | null | null | null | 2021-10-03 | NB HRNBL-1 TVD | null | null | CABOZANTINIB | 100103682 |
| 180003221 | 180002073 | null | null | null | 2017-03-31 | 2017-04-01 | Dinutuximab Beta | null | null | CARBOPLATIN + PACLITAXEL | 101103931 |
| 180003233 | 180002074 | null | null | null | null | 2017-12-17 | Vinorelbine (oral) | null | null | CISPLATIN + ETOPOSIDE | 100041444 |
| 180003267 | 180002075 | null | null | null | null | 2017-06-24 | EVEROLIMUS | null | null | EVEROLIMUS + EXEMESTANE | 100452690 |
| 180003402 | 180002082 | null | null | null | null | 2018-02-01 | Rituximab | null | null | NB HRNBL-1 ISOTRETINOIN | 101521209 |
| 180003493 | 180002087 | null | null | null | 2018-03-30 | 2018-12-29 | Cyclophosphamide oral | null | null | VANDETANIB | 100084772 |